James Hambro & Partners
- SEC CIK
- 0001731152
- Latest filing
- Jul 23, 2026
PFE holding history
Pfizer Inc in every 13F filed by James Hambro & Partners, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PFE overviewAll 13F holders of PFEFull Q2 2026 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −28,700−100.0% | Sold out | Holders |
| Q2 2023 | 28,700 | $1.05M | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 28,700 | $1.17M | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 28,700 | $1.47M | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 28,700 | $1.26M | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 28,700 | $1.51M | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 28,700 | $1.49M | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 28,700 | $1.70M | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 28,700 | $1.23M | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2021 | 28,700 | $1.12M | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2021 | 28,700 | $1.04M | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.